home / stock / npce / npce articles

NPCE Articles, Neuropace Inc. - From 05/14/24

Stock Information
Company Name: Neuropace Inc.
Stock Symbol: NPCE
Market: NASDAQ
Website: neuropace.com
Menu
NPCE NPCE Quote NPCE Short NPCE News NPCE Articles NPCE Message Board
Get NPCE Alerts

News, Short Squeeze, Breakout and More Instantly...
NeuroPace to Participate in Two Healthcare Conferences in May | Benzinga

MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the live...
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 | Benzinga

MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the li...

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference | Benzinga

MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the li...

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

MOUNTAIN VIEW, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a commercial-stage medical device company focused on tra...
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting | Benzinga

MOUNTAIN VIEW, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a commercial-stage medical device company focused on tra...

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference | Benzinga

MOUNTAIN VIEW, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a commercial-stage medical device company focused on tra...

Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position | Benzinga

Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resi...
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023 | Benzinga

MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a commercial-stage medical device company focused on tra...

NeuroPace 10% Owner Trades $75K In Company Stock | Benzinga

ORBIMED ADVISORS LLC, 10% Owner at NeuroPace (NASDAQ:NPCE), reported a large insider sell on October 4, according to a new SEC filing. What Happen...

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference | Benzinga

MOUNTAIN VIEW, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (NASDAQ:NPCE), a commercial-stage medical device company focused on tr...
Previous 10 Next 10